142 related articles for article (PubMed ID: 34653526)
1. Preoperative radiotherapy 5 × 5 Gy and short versus long interval between surgery for resectable rectal cancer: 10-Year follow-up of the randomised controlled trial.
Pach R; Sierzega M; Szczepanik A; Popiela T; Richter P
Radiother Oncol; 2021 Nov; 164():268-274. PubMed ID: 34653526
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up.
Pach R; Kulig J; Richter P; Gach T; Szura M; Kowalska T
Langenbecks Arch Surg; 2012 Jun; 397(5):801-7. PubMed ID: 22170083
[TBL] [Abstract][Full Text] [Related]
3. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
Erlandsson J; Holm T; Pettersson D; Berglund Å; Cedermark B; Radu C; Johansson H; Machado M; Hjern F; Hallböök O; Syk I; Glimelius B; Martling A
Lancet Oncol; 2017 Mar; 18(3):336-346. PubMed ID: 28190762
[TBL] [Abstract][Full Text] [Related]
4. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
[TBL] [Abstract][Full Text] [Related]
5. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.
van Gijn W; Marijnen CA; Nagtegaal ID; Kranenbarg EM; Putter H; Wiggers T; Rutten HJ; Påhlman L; Glimelius B; van de Velde CJ;
Lancet Oncol; 2011 Jun; 12(6):575-82. PubMed ID: 21596621
[TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
7. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
8. Delayed versus immediate surgery following short-course neoadjuvant radiotherapy in resectable (T3N0/N+) rectal cancer.
Kaytan-Saglam E; Balik E; Saglam S; Akgün Z; Ibis K; Keskin M; Dagoglu N; Kapran Y; Gulluoglu M
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1597-1603. PubMed ID: 28374169
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
[TBL] [Abstract][Full Text] [Related]
10. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
11. Preoperative radiotherapy combined with intraoperative radiotherapy improve results of total mesorectal excision in patients with T3 rectal cancer.
Pacelli F; Di Giorgio A; Papa V; Tortorelli AP; Covino M; Ratto C; Bossola M; Valentini V; Sofo L; Miccichè F; Gambacorta MA; Doglietto GB
Dis Colon Rectum; 2004 Feb; 47(2):170-9. PubMed ID: 15043286
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.
Ngan SY; Burmeister B; Fisher RJ; Solomon M; Goldstein D; Joseph D; Ackland SP; Schache D; McClure B; McLachlan SA; McKendrick J; Leong T; Hartopeanu C; Zalcberg J; Mackay J
J Clin Oncol; 2012 Nov; 30(31):3827-33. PubMed ID: 23008301
[TBL] [Abstract][Full Text] [Related]
13. Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study.
Ciseł B; Pietrzak L; Michalski W; Wyrwicz L; Rutkowski A; Kosakowska E; Cencelewicz A; Spałek M; Polkowski W; Jankiewicz M; Styliński R; Bębenek M; Kapturkiewicz B; Maciejczyk A; Sadowski J; Zygulska J; Zegarski W; Jankowski M; Las-Jankowska M; Toczko Z; Żelazowska-Omiotek U; Kępka L; Socha J; Wasilewska-Tesluk E; Markiewicz W; Kładny J; Majewski A; Kapuściński W; Suwiński R; Bujko K;
Ann Oncol; 2019 Aug; 30(8):1298-1303. PubMed ID: 31192355
[TBL] [Abstract][Full Text] [Related]
14. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society.
Siegel R; Burock S; Wernecke KD; Kretzschmar A; Dietel M; Loy V; Koswig S; Budach V; Schlag PM
BMC Cancer; 2009 Feb; 9():50. PubMed ID: 19200365
[TBL] [Abstract][Full Text] [Related]
15. Improved survival with preoperative radiotherapy in resectable rectal cancer.
; Cedermark B; Dahlberg M; Glimelius B; Påhlman L; Rutqvist LE; Wilking N
N Engl J Med; 1997 Apr; 336(14):980-7. PubMed ID: 9091798
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors: A Prospective Multicenter Stratified Randomized Trial.
Deng X; Liu P; Jiang D; Wei M; Wang X; Yang X; Zhang Y; Wu B; Liu Y; Qiu M; Zhuang H; Zhou Z; Li Y; Xu F; Wang Z
Ann Surg; 2020 Dec; 272(6):1060-1069. PubMed ID: 31599809
[TBL] [Abstract][Full Text] [Related]
17. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
18. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
19. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.
Kapiteijn E; Marijnen CA; Nagtegaal ID; Putter H; Steup WH; Wiggers T; Rutten HJ; Pahlman L; Glimelius B; van Krieken JH; Leer JW; van de Velde CJ;
N Engl J Med; 2001 Aug; 345(9):638-46. PubMed ID: 11547717
[TBL] [Abstract][Full Text] [Related]
20. Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment.
Myerson RJ; Genovesi D; Lockett MA; Birnbaum E; Fleshman J; Fry R; Kodner I; Menteer J; Picus J; Read T; Walz B
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):537-43. PubMed ID: 10078634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]